Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pitts

Showing results (211-220 of 268) with videos related to

Pageof 27
Sort By:
BMC Genomics|December 19, 2015
An integrated bioinformatics analysis to dissect kinase dependency in triple negative breast cancerKaren A Ryall, Jihye Kim, Peter J Klauck, et al.
Plos One|November 2, 2017
Evaluation of the efficacy of dasatinib, a Src/Abl inhibitor, in colorectal cancer cell lines and explant mouse modelAaron J Scott, Eun-Kee Song, Stacey Bagby, et al.
Nature Computational Science|March 4, 2024
Population-level comparisons of gene regulatory networks modeled on high-throughput single-cell transcriptomics dataDaniel Osorio, Anna Capasso, S Gail Eckhardt, et al.
Molecular Cancer Therapeutics|March 12, 2015
p53 Family Members Regulate Phenotypic Response to Aurora Kinase A Inhibition in Triple-Negative Breast CancerJohn J Tentler, Anastasia A Ionkina, Aik Choon Tan, et al.
Developmental Biology|July 12, 2022
Peripheral nerve development in zebrafish requires muscle patterning by tcf15/paraxisLauren E Limbach, Rocky L Penick, Rudy S Casseday, et al.
Anti-Cancer Drugs|July 27, 2018
Dual compartmental targeting of cell cycle and angiogenic kinases in colorectal cancer modelsAnna Capasso, Todd M Pitts, Peter J Klauck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2012
Predictive biomarkers of sensitivity to the aurora and angiogenic kinase inhibitor ENMD-2076 in preclinical breast cancer modelsJennifer R Diamond, S Gail Eckhardt, Aik Choon Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2012
Common PIK3CA mutants and a novel 3' UTR mutation are associated with increased sensitivity to saracatinibJohn J Arcaroli, Kevin S Quackenbush, Rebecca W Powell, et al.
Investigational New Drugs|December 31, 2015
Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancersElizabeth R Kessler, S Gail Eckhardt, Todd M Pitts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2011
Preclinical activity of the rational combination of selumetinib (AZD6244) in combination with vorinostat in KRAS-mutant colorectal cancer modelsM Pia Morelli, John J Tentler, Gillian N Kulikowski, et al.
Pageof 27

Showing results (211-220 of 268) with videos related to

Sort By:
Pageof 27
BMC Genomics|December 19, 2015
An integrated bioinformatics analysis to dissect kinase dependency in triple negative breast cancerKaren A Ryall, Jihye Kim, Peter J Klauck, et al.
Plos One|November 2, 2017
Evaluation of the efficacy of dasatinib, a Src/Abl inhibitor, in colorectal cancer cell lines and explant mouse modelAaron J Scott, Eun-Kee Song, Stacey Bagby, et al.
Nature Computational Science|March 4, 2024
Population-level comparisons of gene regulatory networks modeled on high-throughput single-cell transcriptomics dataDaniel Osorio, Anna Capasso, S Gail Eckhardt, et al.
Molecular Cancer Therapeutics|March 12, 2015
p53 Family Members Regulate Phenotypic Response to Aurora Kinase A Inhibition in Triple-Negative Breast CancerJohn J Tentler, Anastasia A Ionkina, Aik Choon Tan, et al.
Developmental Biology|July 12, 2022
Peripheral nerve development in zebrafish requires muscle patterning by tcf15/paraxisLauren E Limbach, Rocky L Penick, Rudy S Casseday, et al.
Anti-Cancer Drugs|July 27, 2018
Dual compartmental targeting of cell cycle and angiogenic kinases in colorectal cancer modelsAnna Capasso, Todd M Pitts, Peter J Klauck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2012
Predictive biomarkers of sensitivity to the aurora and angiogenic kinase inhibitor ENMD-2076 in preclinical breast cancer modelsJennifer R Diamond, S Gail Eckhardt, Aik Choon Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2012
Common PIK3CA mutants and a novel 3' UTR mutation are associated with increased sensitivity to saracatinibJohn J Arcaroli, Kevin S Quackenbush, Rebecca W Powell, et al.
Investigational New Drugs|December 31, 2015
Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancersElizabeth R Kessler, S Gail Eckhardt, Todd M Pitts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2011
Preclinical activity of the rational combination of selumetinib (AZD6244) in combination with vorinostat in KRAS-mutant colorectal cancer modelsM Pia Morelli, John J Tentler, Gillian N Kulikowski, et al.
Pageof 27